Articles Tagged With: Pharmacy
-
New FDA Approvals
Entecavir (Baraclude) by Bristol-Myers Squibb Co. The FDA has announced the approval of entecavir (Baraclude) tablets and oral solution for the treatment of chronic hepatitis B in adults. Entecavir slows the progression of chronic hepatitis B virus (HBV) by interfering with viral reproduction. -
News Brief: Drug formularies can increase health risks
-
In the Pipeline
-
News Brief: HHS releases final privacy standards
-
News Brief: Warning added to zonisamide (Zonegran)
-
News Brief: Patients concerned about medication-related issues
-
News Brief: Many Americans unaware of pharmacist shortage
-
ED Benchmarking Success: Cut medication errors in half with ED pharmacist
-
Groups pleased that final privacy rule lacks a written consent requirement
-
Pharmacists can counsel women about HRT concerns